PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25159853-2	2015	We report a case of a 35-year-old man with BRAF(V600E) metastatic melanoma treated with dabrafenib (as well as ipilimumab and whole brain radiotherapy), who is alive, 25 months after the onset of his DMC.	dmc	200-203	B-Raf proto-oncogene, serine/threonine kinase	Homo sapiens	43-47	
31473636-5	2019	Here, we report a case of BRAF-mutated MM who presented with DMC.	dmc	61-64	B-Raf proto-oncogene, serine/threonine kinase	Homo sapiens	26-30	
25257244-5	2014	Mutation testing of DMC patients should be considered as BRAF inhibitors, and other novel targeted therapies may improve the bleak prognosis associated with this unusual presentation of metastatic melanoma.	dmc	20-23	B-Raf proto-oncogene, serine/threonine kinase	Homo sapiens	57-61